Clinical Trials in Dallas

Showing 11901-11920 of 17,468 trials

A Study of Evacetrapib in Healthy Female Participants

NCT01746732

The purpose of this study is to evaluate the effects of evacetrapib on oral contraceptives (Ortho-Cyclen®) when given to healthy female participants. The amount of female hormones found in the blood will be measured and compared when taken alone and when taken with evaceptrapib. Each woman will participate in two study periods. Information about any side effects that may occur will also be collected.

Healthy Volunteers

Eli Lilly and Company23 participantsStarted Dec 2012

Dallas, Texas, United States

COMPLETEDPhase 1< 1 mile

A Study of Evacetrapib and Digoxin in Healthy Participants

NCT01897493

The main purpose of this study is to determine how much digoxin gets into the blood stream and how long it takes the body to get rid of it when given with the study drug evacetrapib. This study will also look at the effect of evacetrapib on the removal of digoxin from the body by the kidneys. Information about any side effects that may occur will be collected. This study will last approximately 33 days for each participant, not including screening.

Healthy Volunteers

Eli Lilly and Company16 participantsStarted Jul 2013

Dallas, Texas, United States

TERMINATEDPhase 2< 1 mile

Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study

NCT00526071

Study to evaluate the long-term safety, tolerability, and pharmacodynamics (PD) of migalastat hydrochloride (HCl) (migalastat) in participants with Fabry disease

Fabry Disease

Amicus Therapeutics23 participantsStarted Sep 2007

Decatur, Georgia, United States • New York, New York, United States • Dallas, Texas, United States +5 more locations

A Study of Evacetrapib in Healthy Female Participants

A Study of Evacetrapib and Digoxin in Healthy Participants

Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study

Find Trials by Condition in Dallas

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

Medical Therapy of Prostatic Symptoms

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus

The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B

A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

Lifitegrast 5% Ophthalmic Solution and Contact Lens Dryness

A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

Multicenter Continuous Peripheral Nerve Block Surveillance Study

Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life

Post-Market Study of the Modular Revision Hip System

Substance Abuse Treatment to HIV Care (SAT2HIV): The Implementation & Sustainment Facilitation Experiment

Assessing Fitting Guides in Alcon Multifocal Contact Lenses

A Pilot Study to Evaluate the Use of Smart Adherence Technology to Measure Lumacaftor/Ivacaftor Adherence in CF Subjects Homozygous for the F508del CFTR Mutation

Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis

A Study of Axitinib in Advanced Carcinoid Tumors

PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis